Heron Therapeutics Stock Forecast

Sell candidate since May 08, 2026 Loss -64.46%

The Heron Therapeutics stock price gained 3.24% on the last trading day (Friday, 26th Jun 2026), rising from $0.410 to $0.423. During the last trading day the stock fluctuated 4.62% from a day low at $0.411 to a day high of $0.430. The price has risen in 6 of the last 10 days and is up by 4.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 312 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.15 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.312 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -39.06% during the next 3 months and, with a 90% probability hold a price between $0.190 and $0.586 at the end of this 3-month period.

HRTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 12.57%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Heron Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.666. On a fall, the stock will find some support from the short-term average at $0.418. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Heron Therapeutics stock

Heron Therapeutics finds support from accumulated volume at $0.429 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0250 between high and low, or 6.17%. For the last week, the stock has had daily average volatility of 7.63%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HRTX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Heron Therapeutics to open at $0.422, and during the day (based on 14 day Average True Range), to move between $0.405 and $0.455, which gives a possible trading interval of +/-$0.0499 (+/-12.31%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 12.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.429 (0.33%) than the resistance at $0.447 (3.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Heron Therapeutics stock A Buy?

Heron Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.330 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $0.422 ( 1.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk